These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20486430)

  • 1. Characteristics of obesity and its related disorders in China.
    Jia WP; Wang C; Jiang S; Pan JM
    Biomed Environ Sci; 2010 Feb; 23(1):4-11. PubMed ID: 20486430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications.
    Mensah GA; Mokdad AH; Ford E; Narayan KM; Giles WH; Vinicor F; Deedwania PC
    Cardiol Clin; 2004 Nov; 22(4):485-504. PubMed ID: 15501618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.
    Ginsberg HN; MacCallum PR
    J Cardiometab Syndr; 2009; 4(2):113-9. PubMed ID: 19614799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health consequences of obesity and projected future obesity health burden in China.
    Sun X; Yan AF; Shi Z; Zhao B; Yan N; Li K; Gao L; Xue H; Peng W; Cheskin LJ; Wang Y
    Obesity (Silver Spring); 2022 Sep; 30(9):1724-1751. PubMed ID: 36000246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secular Trend of Metabolic Syndrome and Its Components in a Cohort of Iranian Adults from 2001 to 2013.
    Khosravi-Boroujeni H; Sarrafzadegan N; Sadeghi M; Roohafza H; Talaei M; Ng SK; Phung H; Pourmogaddas A; Ahmed F
    Metab Syndr Relat Disord; 2017 Apr; 15(3):137-144. PubMed ID: 28135122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes.
    Ma CM; Lu N; Wang R; Liu XL; Lu Q; Yin FZ
    Sci Rep; 2017 Aug; 7(1):9843. PubMed ID: 28852155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease risks of childhood obesity in China.
    Li YP; Yang XG; Zhai FY; Piao JH; Zhao WH; Zhang J; Ma GS
    Biomed Environ Sci; 2005 Dec; 18(6):401-10. PubMed ID: 16544522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological characteristics of metabolic syndrome among Kazakh children aged from 6 to 13 in Xinjiang, China].
    Li M; Zhang T; Xu PR
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Apr; 34(4):336-41. PubMed ID: 23937836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome, hypertension, and nervous system injury: Epidemiological correlates.
    Ricci G; Pirillo I; Tomassoni D; Sirignano A; Grappasonni I
    Clin Exp Hypertens; 2017; 39(1):8-16. PubMed ID: 28071980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Globalization and health: proceedings of a conference at the Nuffield Trust, London, May 19-20, 2005.
    Obesity (Silver Spring); 2006 Jan; 14(1):4-13. PubMed ID: 16493117
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of Metabolic Syndrome in individuals with Type 2 Diabetes Mellitus.
    Lira Neto JC; Xavier MA; Borges JW; Araújo MF; Damasceno MM; Freitas RW
    Rev Bras Enferm; 2017 Apr; 70(2):265-270. PubMed ID: 28403288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal obesity and metabolic syndrome in South Asians: prevention and management.
    Jayawardena R; Sooriyaarachchi P; Misra A
    Expert Rev Endocrinol Metab; 2021 Nov; 16(6):339-349. PubMed ID: 34586004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity as a Source of Endogenous Compounds Associated With Chronic Disease: A Review.
    Smith CJ; Perfetti TA; Hayes AW; Berry SC
    Toxicol Sci; 2020 Jun; 175(2):149-155. PubMed ID: 32207534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Obesity and Metabolic Health on Vascular Health.
    Rhee EJ
    Endocrinol Metab (Seoul); 2022 Feb; 37(1):1-8. PubMed ID: 35255597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of different waist circumference cut-off values in predicting metabolic syndrome prevalence and risk factors in adults in China.
    Zhou HC; Lai YX; Shan ZY; Jia WP; Yang WY; Lu JM; Weng JP; Ji LN; Liu J; Tian HM; Ji QH; Zhu DL; Chen L; Guo XH; Zhao ZG; Li Q; Zhou ZG; Ge JP; Shan GL
    Biomed Environ Sci; 2014 May; 27(5):325-34. PubMed ID: 24827713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal obesity and the metabolic syndrome: a surgeon's perspective.
    Mathieu P
    Can J Cardiol; 2008 Sep; 24 Suppl D(Suppl D):19D-23D. PubMed ID: 18787732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediators of diabetic neuropathy: is hyperglycemia the only culprit?
    Grisold A; Callaghan BC; Feldman EL
    Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):103-111. PubMed ID: 28098594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.